The Path to Reemergence

03.11.2022

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma Manufacturing on lessons learned from COVID, and the path forward to future pandemic preparedness.

Read the full article here.

CITATION

K. Langhauser, "Emergent BioSolutions: The path to reemergence," Pharma Manufacturing, February 10, 2022.

Emergent CDMO

COVID-19 In The News

Thought Leadership
In The News
Webinars
White Papers
Video Library
Case Studies

06.29.2023

Case Study Corner: Streamlining R&D to Manufacturing

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...

10.01.2020

Bloomberg: The Way Ahead

Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...

04.14.2022

Molecule to Market: Inside the Outsourcing Space

Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...